Orion Infusions (DHA:ORIONINFU) Net Issuance of Preferred Stock : BDT0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Orion Infusions Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Orion Infusions's net issuance of preferred for the three months ended in Dec. 2024 was BDT0.0 Mil. The number is 0, which means that Orion Infusions has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Orion Infusions's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2024 was BDT0.0 Mil.

Orion Infusions Net Issuance of Preferred Stock Historical Data

The historical data trend for Orion Infusions's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Net Issuance of Preferred Stock Chart

Orion Infusions Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Orion Infusions Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Orion Infusions Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0.0 Mil.

Orion Infusions Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Orion Infusions's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Net Issuance of Preferred Stock

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon I/A, Orion House, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions Headlines

No Headlines